
Daprodustat is indicated for the treatment of anemia due to chronic kidney disease (CKD) in adults who have been receiving dialysis for at least four months.
Daprodustat has not been shown to improve quality of life, fatigue, or patient well-being.
Daprodustat is not indicated for use:
• As a substitute for red blood cell transfusions in patients who require immediate correction of anemia.
• For treatment of anemia of chronic kidney disease in patients who are not on dialysis.
from FDA,2023.02
LuciusVersionofDaprodustat:DosageandAdministration,Indications,PrecautionsDaprodustat is indicated f···【more】
Recommended:552025-17-12
Daprodustat is indicated for the treatment of anemia due to chronic kidney disease (CKD) in adults who have been receiving dialysis for at least four months.【more】
Article source:Lucius LaosRelease date:2026-01-05Recommended:9
LuciusVersionofDaprodustat:DosageandAdministration,Indications,PrecautionsDaprodustat is indicated for the treatment of anemia caused by chronic kidney disease in adult patients wh···【more】
Article source:Lucius LaosRelease date:2025-12-17Recommended:55

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: